• Selected from a highly competitive applicant pool, which included law, business, sciences, undergraduate, and medical school students, to evaluate early-stage technologies through a learn-by-doing apprenticeship model• Elected as leader of diligence team to assess a therapeutic and medical device technologies and ensure deal deadlines were achieved, 88% of the investment committee agreed with team’s decision to provide funding• $20M venture fund investing in technologies developed at The University of Chicago, Argonne National Laboratory, Fermilab, and Marine Biological Laboratory

• Centralized an inventory strategy for predicting raw material levels, recommending inventory changes to over 70% of items• Discovered $4M in inactive raw materials in stock and partnered with resellers to structure consumables repurchase program• Gained experience with gene therapy manufacturing, GMP setup, regulatory, fundraising, and pre-clinical supply chain planning• Collaborated with gene therapy leaders from Avexis (acquired by Novartis for $9B as one of the first gene therapy successes) and top tier funded company including investments from ARCH Venture Partners, Goldman Sachs, Eli Lilly, and Deerfield

• Built key performance dashboards and benchmarks to monitor current clinical trial activation timelines to maintain NCI designation, identifying potential strategies to decrease cycle times by 20%• Enhanced historical data to quantify CPT code frequencies and average cost for improved gyno-oncology clinical trial budgeting• Formulated financial models to drive a centralized staffing change to decrease overhead costs across all clinical trials

• Promoted to Product Specialist.• Lead negotiations of over $12M instrumentation, service, and consumables deals.• Grew revenue by more than 50% in Southeast Region (NC, SC, TN, GA, FL, MS, and AL) while exceeding target revenue.• Awarded the 2019 High Achievers Club, which is given to the top 2% performers.• Took on stretch projects including expanding geography to NY and NJ Region.• Successful results driven by teamwork and strategic relationship management execution.• Coordinated a team including subject matter experts from product marketing, scientific applications, and inside sales to drive value for target customers.• Recognized in Cilenti et al. Scientific Reports. 2020 exemplifying collaborative mindset.• Author in Elsakr et al. Journal of Visualized Experiments. 2019 for strategic partnership in developing 3-D cell analysis applications.

• Promoted to position following the $235M acquisition of Seahorse Bioscience located in Boston, MA.• Supported over $22M and over 90 deals in emerging functional metabolism and cell analysis space through opportunity generation, lead qualification, and deal closing.• Ranked Best Sales Development Representative in 2016 and 2017.• Developed knowledge of global field sales organization, revenue forecasting, new business generation, and target customers in cancer, immunotherapy, and stem cell research fields.• Worked cross functionally with Product Managers to position products at industry workshops and target strategic accounts.• Built relationships in biotech, biopharma, and academic accounts.

• Hired into Undergraduate New Hire Program starting in Chicago, IL.• Delivered technical service on chromatography-based lab instruments to improve reliability and productivity. • Collaborated with sales, supply chain, and management to bring the highest quality of service to customers. • Developed strong relationships in academia, pharmaceuticals, energy, and food industries by engaging customers to meet their needs.

• Selected as one of two interns from a national applicant pool located in Fort Collins, CO.• Helped develop DNA-based vaccines for dengue virus, yellow fever, and West Nile virus in the laboratory of Dr. Jeff Chang.• Implemented experiments and reported lab data so the team could make conclusions and direct future research.